Additives and Fillers in Concrete
Newman Projections
Renewal of Skin Epidermal Stem Cells
Superplasticizers
Tissue Renewal without Stem Cells
Fibril-associated Collagen
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 9, 2026

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
This paper introduces two new collagen-based dermal fillers, ArteFill and Evolence, both containing lidocaine for comfort. These products are designed to meet the needs of men seeking long-lasting facial corrections. ArteFill has been available in the U.S. since 2006, while Evolence is expected to launch in 2008. A Canadian dermatologist shares insights from hundreds of injections, offering tips and precautions to improve patient outcomes. The fillers are positioned as suitable options for male patients due to their long-term effects and ease of administration.
Area of Science:
Background:
Many men seek long-lasting facial corrections. Traditional fillers may not meet their needs. Dermal fillers have evolved to include collagen-based options. Collagen-based fillers offer unique properties. Some fillers contain lidocaine for pain reduction. Men often prefer treatments with extended duration. Few studies focus on male aesthetic preferences. New products aim to address these specific needs.
Purpose Of The Study:
This paper describes two new collagen-based fillers. Both contain lidocaine for comfort during injection. The goal is to evaluate their appeal to men. The products are marketed as long-lasting or permanent. The paper shares clinical experience from a Canadian dermatologist. Over hundreds of injections have been performed. Tips are provided to improve patient outcomes. The study highlights practical considerations for use.
Main Methods:
The authors describe ArteSense/ArteFill and Evolence. Both are collagen-based with lidocaine. ArteFill has been available in the U.S. since 2006. Evolence is expected in the U.S. in 2008. Clinical experience is based on hundreds of injections. A Canadian dermatologist provides insights. Administration techniques are outlined. Precautions are included to optimize results.
Main Results:
ArteFill and Evolence are collagen-based fillers. Both contain lidocaine to reduce injection discomfort. ArteFill has been used in the U.S. since 2006. Evolence is anticipated in the U.S. in 2008. The Canadian dermatologist administered hundreds of syringes. Practical tips are shared for optimal outcomes. Precautions include avoiding overfilling in certain areas. Patient satisfaction is reported with both products.
Conclusions:
ArteFill and Evolence offer long-term correction options. Their collagen-based formulation suits male patients. Lidocaine inclusion improves injection comfort. Clinical experience supports their use in men. The Canadian dermatologist’s insights are valuable. Proper technique is essential for best results. Both products are positioned for male aesthetic needs. They represent recent advancements in filler technology.
Both are collagen-based with lidocaine, but Evolence is newer and expected to launch in the U.S. in 2008.
Men often seek long-lasting or permanent correction, which these fillers aim to provide.
Lidocaine is included to reduce injection discomfort and improve patient experience.
A Canadian dermatologist has administered hundreds of syringes of both ArteFill and Evolence.
Evolence is expected to reach the American market in 2008.
Avoid overfilling in certain areas and follow administration tips from experienced practitioners.